Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Lilly/Taisho sign technology transfer agreement

Feb. 13, 1997

IDEC receives patent coverage for platform technology

Feb. 12, 1997

Merck & Co. and Costa Rican institute renew biological diversity agreement

Feb. 11, 1997

Genentech funds basic research related to human birth defects

Feb. 10, 1997

Vyrex gene discovery platform receives patent coverage

Feb. 10, 1997

Zynaxis sells drug delivery technology

Feb. 7, 1997

Abgenix reports significant advance in human antibody technology

Feb. 6, 1997

LifeTECH and Pall announce collaboration

Feb. 6, 1997

ICOS/Glaxo Wellcome collaboration modified

Feb. 4, 1997

Cytogen/Elan oral drug delivery collaboration advances

Feb. 4, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...